BACKGROUND: Alaska Native persons experience gastric cancer incidence and mortality rates that are three to four times higher than in the general United States population. OBJECTIVE: To evaluate pepsinogen I, pepsinogen I/II ratio, anti-Helicobacter pylori and cytotoxin-associated gene A (CagA) antibody levels, and blood group for their associations with gastric cancer development in Alaska Native people. METHODS: The present analysis was a retrospective case-control study that matched gastric cancers reported to the Alaska Native Tumor Registry from 1969 to 2008 to three controls on known demographic risk factors for H pylori infection, using sera from the Alaska Area Specimen Bank. Conditional logistic regression evaluated associations between serum markers and gastric cancer. RESULTS: A total of 122 gastric cancer cases were included, with sera predating cancer diagnosis (mean = 13 years) and 346 matched controls. One hundred twelve cases (91.8%) and 285 controls (82.4%) had evidence of previous or ongoing H pylori infection as measured by anti-H pylori antibody levels. Gastric cancer cases had a 2.63-fold increased odds of having positive anti-H pylori antibodies compared with their matched controls (P=0.01). In a multivariate model, noncardia gastric cancer (n=94) was associated with anti-H pylori antibodies (adjusted OR 3.92; P=0.004) and low pepsinogen I level (adjusted OR 6.04; P=0.04). No association between gastric cancer and blood group, anti-CagA antibodies or pepsinogen I/II ratio was found. CONCLUSION: Alaska Native people with gastric cancer had increased odds of previous H pylori infection. Low pepsinogen I level may function as a precancer marker for noncardia cancer.
BACKGROUND: Alaska Native persons experience gastric cancer incidence and mortality rates that are three to four times higher than in the general United States population. OBJECTIVE: To evaluate pepsinogen I, pepsinogen I/II ratio, anti-Helicobacter pylori and cytotoxin-associated gene A (CagA) antibody levels, and blood group for their associations with gastric cancer development in Alaska Native people. METHODS: The present analysis was a retrospective case-control study that matched gastric cancers reported to the Alaska Native Tumor Registry from 1969 to 2008 to three controls on known demographic risk factors for H pylori infection, using sera from the Alaska Area Specimen Bank. Conditional logistic regression evaluated associations between serum markers and gastric cancer. RESULTS: A total of 122 gastric cancer cases were included, with sera predating cancer diagnosis (mean = 13 years) and 346 matched controls. One hundred twelve cases (91.8%) and 285 controls (82.4%) had evidence of previous or ongoing H pylori infection as measured by anti-H pylori antibody levels. Gastric cancer cases had a 2.63-fold increased odds of having positive anti-H pylori antibodies compared with their matched controls (P=0.01). In a multivariate model, noncardia gastric cancer (n=94) was associated with anti-H pylori antibodies (adjusted OR 3.92; P=0.004) and low pepsinogen I level (adjusted OR 6.04; P=0.04). No association between gastric cancer and blood group, anti-CagA antibodies or pepsinogen I/II ratio was found. CONCLUSION: Alaska Native people with gastric cancer had increased odds of previous H pylori infection. Low pepsinogen I level may function as a precancer marker for noncardia cancer.
Authors: B C Wong; S K Lam; C K Ching; W H Hu; L Y Ong; B W Chen; Z Gao; J S Chen; X W Jiang; X H Hou; J Y Lu; W H Wang; J Ho; S T Yuen; K C Lai; E Kwok; W M Hui; A Covacci Journal: Aliment Pharmacol Ther Date: 1999-10 Impact factor: 8.171
Authors: F Umlauft; E B Keeffe; F Offner; G Weiss; H Feichtinger; E Lehmann; S Kilga-Nogler; G Schwab; A Propst; K Grussnewald; G Judmaier Journal: Am J Gastroenterol Date: 1996-10 Impact factor: 10.864
Authors: J Parsonnet; I M Samloff; L M Nelson; N Orentreich; J H Vogelman; G D Friedman Journal: Cancer Epidemiol Biomarkers Prev Date: 1993 Sep-Oct Impact factor: 4.254
Authors: J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245
Authors: M Yoshihara; K Sumii; K Haruma; K Kiyohira; N Hattori; Y Kitadai; K Komoto; S Tanaka; G Kajiyama Journal: Am J Gastroenterol Date: 1998-07 Impact factor: 10.864
Authors: Leisha Diane Nolen; Dana Bruden; Karen Miernyk; Brian J McMahon; Frank Sacco; Wayne Varner; Tom Mezzetti; Debby Hurlburt; James Tiesinga; Michael G Bruce Journal: Int J Circumpolar Health Date: 2018-12 Impact factor: 1.228
Authors: Sarah H Nash; Garrett L Zimpelman; Keri N Miller; James H Clark; Carla L Britton Journal: Int J Circumpolar Health Date: 2022-12 Impact factor: 1.941
Authors: Leisha D Nolen; Sara Bressler; Stephen M Vindigni; Keri Miller; Sarah Nash Journal: Clin Transl Gastroenterol Date: 2021-06-23 Impact factor: 4.396
Authors: Stephanie C Melkonian; Dornell Pete; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Michael G Bruce; Mary C White Journal: Am J Gastroenterol Date: 2020-12 Impact factor: 12.045